Diagnostic uncertainty of isolated skull lesion in prostate cancer- Role of SPECT/CT

Document Type : Case Report


Department of Nuclear Medicine and PET, Post Graduate Institute of Medical Education and Research, Chandigarh, India


Skeletal involvement is the second most common site of metastases after lymph nodal metastases in patients with prostate cancer. The skeletal metastases from prostate cancer are osteoblastic in nature and show increased tracer avidity on the bone scan. Focal tracer avid lesion in skeleton especially in skull requires the careful examination by further investigation. The patients with skull metastases are commonly asymptomatic at presentation, but some may have the mass lesion effect .The occurrence of solitary skull metastatic lesion is rare and the metastasis in the existing tracer uptake should be ruled out with the help of high resolution or hybrid imaging modality. We present a known case of prostate cancer who presented with pain in the right temporal region and highlight the  utility of the single photon emission computed tomography/computed tomography (SPECT/CT) imaging in localization and characterization of the isolated focal tracer uptake in the skull region found in bone scan.


Main Subjects

Hamaoka T, Madewell JE, Podoloff DA, Hortobagyi GN, Ueno NT. Bone imaging in metastatic breast cancer. J Clin Oncol. 2004 Jul 15;22(14):2942-53.
Rybak LD, Rosenthal DI. Radiological imaging for the diagnosis of bone metastases. Q J Nucl Med. 2001 Mar;45(1):53-64.
Sharma P, Jain TK, Reddy RM, Faizi NA, Bal C, Malhotra A, Kumar R. Comparison of single photon emission computed tomography-computed tomography, computed tomography, single photon emission computed tomography and planar scintigraphy for characterization of isolated skull lesions seen on bone scintigraphy in cancer patients. Indian J Nucl Med. 2014 Jan;29(1):22-9.
Bubendorf L, Schöpfer A, Wagner U, Sauter G, Moch H, Willi N, Gasser TC, Mihatsch MJ. Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients. Hum Pathol. 2000 May;31(5):578-83.
Long MA, Husband JE. Features of unusual metastases from prostate cancer. Br J Radiol. 1999 Oct;72(862):933-41.
Gnanasegaran G, Cook G, Adamson K, Fogelman I. Patterns, variants, artifacts, and pitfalls in conventional radionuclide bone imaging and SPECT/CT. Semin Nucl Med. 2009 Nov;39(6):380-95.
Rotta FT, Romano JG. Skull base metastases causing acute bilateral hypoglossal nerve palsy. J Neurol Sci. 1997 May 1;148(1):127-9.
Stark AM, Eichmann T, Mehdorn HM. Skull metastases: clinical features, differential diagnosis, and review of the literature. Surg Neurol. 2003 Sep;60(3):219-25; discussion 225-6.
Fervenza FC, Wolanskyj AP, Eklund HE, Richardson RL. Brain metastasis: an unusual complication from prostatic adenocarcinoma. Mayo Clin Proc. 2000 Jan;75(1):79-82.
Salvati M, Frati A, Russo N, Brogna C, Piccirilli M, D'Andrea G, Occhiogrosso G, Pichierri A, Caroli E. Brain metastasis from prostate cancer. Report of 13 cases and critical analysis of the literature. J Exp Clin Cancer Res. 2005 Jun;24(2):203-7.
McLoughlin LC, O'Kelly F, O'Brien C, Sheikh M, Feeney J, Torreggiani W, Thornhill JA. The improved accuracy of planar bone scintigraphy by adding single photon emission computed tomography (SPECT-CT) to detect skeletal metastases from prostate cancer. Ir J Med Sci. 2014 Nov 14. [Epub ahead of print].
Gayed IW, Kim EE, Awad J, Joseph U, Wan D, John S.  The value of fused SPECT/CT in the evaluation of solitary skull lesion. Clin Nucl Med. 2011 Jul;36(7):538-41.
Horger M, Eschmann SM, Pfannenberg C, Vonthein R, Besenfelder H, Claussen CD, Bares R. Evaluation of combined transmission and emission tomography for classification of skeletal lesions. AJR Am J Roentgenol. 2004 Sep;183(3):655-61.